Scientific Sessions 2024  /  Annual Lipid Updates - 2024  /  Lipoprotein(a): Modifiable Risk Factor, Update in Targeted Therapies
Logo

American Heart Association

  109
  0

Final ID:

Lipoprotein(a): Modifiable Risk Factor, Update in Targeted Therapies

  • Yeang, Calvin  ( University of California San Diego , San Diego , California , United States )
  • Bhatia, Harpreet  ( University of California San Diego , San Diego , California , United States )
  • Mehta, Anurag  ( Virginia Commonwealth University , Glen Allen , Virginia , United States )
    • Author Disclosures:
    Calvin Yeang: No Answer | Harpreet Bhatia: DO have relevant financial relationships ; Consultant:Kaneka:Past (completed) ; Advisor:Arrowhead:Active (exists now) ; Advisor:Abbott:Active (exists now) ; Advisor:Novartis:Active (exists now) ; Consultant:Novartis:Active (exists now) | Anurag Mehta: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Annual Lipid Updates - 2024

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Controversies in Nutrition and Lipids

Anderson Cheryl, Polonsky Tamar

New and Emerging Targets for Lowering LDL-Cholesterol and Triglycerides: ANGPTL3, CETP, APOC-III

Kastelein John, Ray Kausik

More abstracts from these authors:
Managing Obesity and MASLD - Whose Job Is It?

Jastreboff Ania, Woodhouse Sheila, Mehta Anurag

Lp(a) may be little but has might: a review of recent lp(a) lowering trials

Bajaj Archna, Yeang Calvin

You have to be authorized to contact abstract author. Please, Login
Not Available